AVADEL PHARMACEUTICALS PLC (AVDL) Marketable Securities, Current USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Avadel Pharmaceuticals Plc quarterly Marketable Securities, Current history and growth rate from 2010 to 2024.
  • Avadel Pharmaceuticals Plc Marketable Securities, Current for the quarter ending March 31, 2024 was $53M, a 202% increase year-over-year.
Marketable Securities, Current, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $53M +$35.5M +202% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $73.9M +$51.4M +228% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $101M +$55.6M +122% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $111M +$60.5M +121% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $17.5M -$45.1M -72% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $22.5M -$84M -78.9% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $45.8M -$77.2M -62.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $50M -$85.7M -63.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $62.6M -$83.2M -57.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $107M -$43.2M -28.8% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $123M -$25.5M -17.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $136M -$679K -0.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $146M +$106M +265% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $150M +$95.3M +175% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $148M +$88.9M +149% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $136M +$74.2M +119% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $40M -$30.2M -43.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $54.4M -$36.2M -40% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $59.6M -$47.8M -44.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $62.2M -$72.5M -53.8% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $70.2M -$87M -55.4% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $90.6M +$13.1M +16.9% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $107M +$29.3M +37.4% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $135M +$4.34M +3.33% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $157M +$10.3M +7% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $77.5M -$37.5M -32.6% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $78.2M -$52.7M -40.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $130M -$674K -0.52% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $147M +$24.9M +20.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $115M +$35.2M +44.2% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $131M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $131M +$70.1M +115% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $122M +$47.4M +63.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $79.7M +$26.7M +50.2% Dec 31, 2015 10-K 2017-03-28
Q2 2015 $60.9M +$37.1M +156% Jun 30, 2015 6-K 2015-12-31
Q1 2015 $74.6M +$46.6M +166% Mar 31, 2015 6-K 2015-07-10
Q4 2014 $53.1M +$52.7M +13135% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $52.5M +$51M +3464% Sep 30, 2014 6-K 2014-11-17
Q2 2014 $23.8M +$22.4M +1613% Jun 30, 2014 6-K 2014-08-08
Q1 2014 $28M Mar 31, 2014 6-K 2014-07-08
Q4 2013 $401K -$6.01M -93.7% Dec 31, 2013 20-F/A 2015-10-01
Q3 2013 $1.47M Sep 30, 2013 6-K 2014-01-15
Q2 2013 $1.39M -$14.3M -91.2% Jun 30, 2013 6-K 2013-12-06
Q4 2012 $6.41M -$14.6M -69.5% Dec 31, 2012 20-F/A 2015-10-01
Q2 2012 $15.7M Jun 30, 2012 6-K 2012-12-14
Q1 2012 $18.4M Mar 31, 2012 6-K 2012-09-13
Q4 2011 $21M -$2.12M -9.17% Dec 31, 2011 20-F/A 2014-04-30
Q4 2010 $23.2M Dec 31, 2010 20-F 2013-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.